United Kingdom· GB-APID-42890511000001106
Exblifep 2g/0.5g powder for concentrate for solution for infusion vials
A medicinal product containing cefepime + enmetazobactam, registered in United Kingdom by Advanz Pharma.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cefepime + Enmetazobactam
- Manufacturer
- Advanz Pharma
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05021691004660
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cefepime + enmetazobactam in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEXBLIFEPADVANZ PHARMA Limited, Dublin
- SpainEXBLIFEP 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONAdvanz Pharma Limited
- FinlandEXBLIFEPAdvanz Pharma Limited
- FranceEXBLIFEP 2 g/0,5 g, poudre pour solution à diluer pour perfusionADVANZ PHARMA LIMITED
- IrelandEXBLIFEP 2 g/0.5 g powder for concentrate for solution for infusionAdvanz Pharma Limited
- IcelandEXBLIFEPADVANZ PHARMA Limited
- NetherlandsEXBLIFEP 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusieAdvanz Pharma Limited
- NorwayExblifepAdvanz Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Exblifep
- Liechtenstein · Exblifep
- Norway · Exblifep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a0edd182-6279-4dc9-86ea-b5331f9620ae GET /v1/drugs/a0edd182-6279-4dc9-86ea-b5331f9620ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42890511000001106",
"desc": "Exblifep 2g/0.5g powder for concentrate for solution for infusion vials (Advanz Pharma)",
"form": "Powder for solution for infusion",
"vpid": "42894511000001102",
"source": "dmd",
"vtm_id": "42894211000001100",
"strength": "500 mg",
"substance": "Cefepime + Enmetazobactam",
"ingredient": "Enmetazobactam",
"supplier_code": "24129411000001106"
}See everything about cefepime + enmetazobactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.